Race Oncology |
High $1.29 |
Low $1.18 |
Trades 155 |
Turnover $303,224 |
Volume 249,053 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (14-Nov) $307,828,256 (417th) |
Close (30-Jun) $1.23 |
Volume (30-Jun) 249,053 |
Shortsold (9-Nov) 19,354 (0.01%) (577th) |
|
52w High $3.79 |
52w Low $1.40 |
P/E - |
EPS -0.06 |
Race Oncology Announces On-Market Share Buyback
RAC released this announcement to the ASX on 9 June 2022, 9:20. The announcement is marked as price sensitive, and is 2 page(s) in length and 91.49kb in size.
You can view all announcements from RAC and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAC was 0.000% short sold according to ASIC data. It was ranked the 687th most shorted stock on the ASX. It is now ranked as the 577th most shorted stock on the ASX with 0.010% of total shares short sold as of the latest reported data (09 November 2026).
| Other Recent Announcements from RAC | |
|---|---|
| Notification of cessation of securities - RAC | 29 June 2023, 9:54 |
| Proposed issue of securities - RAC | 29 June 2023, 9:52 |
| Initial Director's Interest Notice | 29 June 2023, 9:46 |
| Race Oncology Announces On-Market Share Buyback | 9 June 2022, 9:20 |
| EMD AML MDS Trial Expands to Europe | 8 June 2022, 9:31 |
| Zantrene AML trial in Israel advances to Phase 2 | 27 May 2022, 9:41 |
| Trading Halt | 26 May 2022, 13:44 |
If you were already registered, log in here.